Obama nominates Richard Verma as new US envoy to India

September 19, 2014

Washington, Sep 19: President Barack Obama today nominated Indian-American, Richard Rahul Verma, as the next US Ambassador to India, ahead of Prime Minister Narendra Modi's visit to Washington later this month.

Richard VermaIf confirmed by the US Senate, Verma, who earlier served as the Assistant Secretary of State for Legislative Affairs and is now in the private sector, would be the first Indian-American to serve as the top US diplomatic position in New Delhi.

Obama announced his nomination along with several other key administration appointments.

"I am grateful that these impressive individuals have chosen to dedicate their talents to serving the American people at this important time for our country. I look forward to working with them in the months and years ahead," Obama said in a statement.

The US Embassy in New Delhi is currently headed by a Charge d'affaires, Kathleen Stephens.

Verma, 45, said to be a close confidant of the President and also former Secretary of State Hillary Clinton, currently serves as Senior Counselor at Steptoe & Johnson LLP and Albright Stonebridge Group. He is also a Senior National Security Fellow at the Center for American Progress.

Previously, he was Assistant Secretary for Legislative Affairs at the Department of State from 2009 to 2011 and Partner at Steptoe and Johnson LLP from 2007 to 2009.

He was Senior National Security Advisor, Counsel and Foreign Policy Advisor to the Senate Majority Leader Harry Reid from 2002 to 2007, and an Associate at Steptoe & Johnson from 1998 to 2002.

Verma served on active duty in the US Air Force from 1994 to 1998 and received, among other decorations, the Meritorious Service Medal and Air Force Commendation Medal.

Earlier in his career, Verma was a Field Representative for the National Democratic Institute in Eastern Europe and worked in the House of Representatives for Congressman John P Murtha.

He served on the Commission on the Prevention of Weapons of Mass Destruction, Proliferation and Terrorism in 2008 and has been a member of the Secretary of State's Foreign Affairs Policy Board.

Verma currently serves on the boards of Human Rights First, the Clinton Foundation, and the National Democratic Institute. He received a BS from Lehigh University, a JD from American University, and an LLM from Georgetown University Law Center.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 29,2020

Paris, Jun 29: More than half a million people have been killed by the novel coronavirus, nearly two thirds of them in the United States and Europe, according to an news agency tally at 2200 GMT Sunday based on official sources.

The official death count for the disease now stands at 500,390 deaths from 10,099,576 cases recorded worldwide. The United States has suffered the highest death count (125,747), followed by Brazil (57,622) and the United Kingdom (43,550).

The tallies, using data collected by AFP from national authorities and information from the World Health Organization (WHO), probably reflect only a fraction of the actual number of infections.

Many countries are testing only the most serious cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 13,2020

New Delhi, Jul 13: Google CEO Sundar Pichai on Monday announced an investment of Rs 75,000 crore or approximately US$10 billion into India over the next five to seven years through 'Google for India Digistation Fund'.

This move is significant as it comes in the middle of the COVID-19 pandemic and as multinational companies across the world look at alternative investment destinations.

"Excited to announce Google for India Digitisation Fund. Through it, we will invest Rs 75,000 crore or approx US$10 Billon into India over the next 5-7 yrs. We'll do this through a mix of equity investments, partnerships and operational infrastructure in ecosystem investments," said Pichai.

Pichai along with Union Minister Ravi Shankar Prasad virtually attended the sixth annual edition of Google for India.

"This is a reflection of our confidence in the future of India and its digital economy," said Pichai.
He added that the investments will focus on four areas important to India's digitisation.

Listing out the areas, Pichai elaborated, "First enabling affordable access and information to every Indian in their own language. Second, building new products and services that are deeply relevant to India's unique needs. Third, empowering businesses as they continue or embark on the digital transformation. Fourth, leveraging technology in AI for social good in areas like health, education and agriculture."

"When I was young, every piece of technology brought new opportunities to learn and grow but I always had to wait for it to arrive from some places. Today people in India no more have to wait for technology to come to you. A whole new generation of technologies is happening in India first," said Pichai.

Earlier today Prime Minister Narendra Modi interacted with Pichai and discussed a range of subjects like a new work culture in coronavirus times, data security and cyber safety.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.